Treatment Action Group (TAG) analyzes and reports on the annual
funding of tuberculosis (TB ) research and development (R&D). The top 40 TB
research funding institutions were surveyed for actual disbursements made for TB
R&D in fiscal years 2005, 2006, and now 2007. The three-year data reveal trends in
funding and demonstrates an alarming shortfall in the growth of TB R&D during the
initial years covered by The Global Plan to Stop TB: 2006–2015.
Audiences:
Health Professionals
International Agencies
Managers and Supervisors
Policy Makers
Focus Area:
TB
Subjects:
Advocacy/Communications
Program Management
Publication Date:
2009
Format:
Report
Last Updated Date:
Publication ID:
33504